Simple bike test could revolutionize lung cancer risk assessment

NCT ID NCT07506889

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test if a simple, low-intensity cycling exercise combined with a handheld monitor can predict serious complications in lung cancer patients before surgery or other treatments. Researchers will include 500 adults with suspected lung cancer. The goal is to make risk assessment easier and more accessible than current complex tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide a simple, low-cost exercise test to better predict which lung cancer patients are at high risk for complications after surgery or during treatment.
What could go wrong
This is an observational study, not a treatment trial. The test may not prove accurate enough to change clinical practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END TIDAL CARBON DIOXIDE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Clinical Physiology

    Lund, Sweden

  • Department of Pulmonology, Blekinge Hospital

    Karlskrona, Sweden

  • Department of Pulmonology, Kalmar County Hospital

    Kalmar, Sweden

  • Department of Pulmonology, Ryhov

    Jönköping, Sweden

  • Department of Pulmonology, University Hospital

    Linköping, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.